Profil
David Apelian is currently Chief Executive Officer at Theolytics Ltd. since 2024.
Formerly, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. from 2022 to 2024, Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013, Clinical Director-Infectious Diseases Group at Bristol Myers Squibb Co. from 2002 to 2004, Clinical Director-Hepatology Department at Schering-Plough Corp.
from 1999 to 2002, and Vice President at Wyeth Pharmaceuticals LLC.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA from Quinnipiac University.
Aktive Positionen von David Apelian
| Unternehmen | Position | Beginn |
|---|---|---|
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Vorstandsvorsitzender | 17.12.2024 |
Ehemalige bekannte Positionen von David Apelian
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Vorstandsvorsitzender | 01.09.2024 |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Vorstandsvorsitzender | 04.10.2022 |
| ACHILLION PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.12.2017 |
| GLOBEIMMUNE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von David Apelian
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
GlobeImmune, Inc.
GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac University
Quinnipiac University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Health Technology |
















